ELOXX

Eloxx Pharmaceuticals based in Israel is a Pontifax portfolio company established in 2013 by Dr. Silvia Noiman, that serves as its Executive Chairman and Dr. Shmuel Tuvia. The company, is a biopharmaceutical company focused on discovery, development and commercialization of compounds for the treatment of genetic diseases caused by nonsense mutations including: Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, Tay-Sachs Hurler syndrome and many ... others. Eloxx Pharmaceuticals approach and knowhow allows moving rapidly from target drugs discovery program to clinical drug candidates. Building a robust pipeline of molecules designed for an array of nonsense genetic diseases. Translation of mRNA to a protein is the event where the cellular machinery, i.e. ribosome, ultimately dictates the quantity and timing for each protein to be produced. Thus, molecules that induce ribosomal readthrough overcome the nonsense mutations and allow production of a full-length functional protein. These molecules hold great therapeutic potential for the treatment of many genetic diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

ELOXX

Social Links:

Twitter

Industry:

Biotechnology Genetics Health Care

Founded:

2013-01-01

Address:

Waltham, Massachusetts, United States

Country:

United States

Website Url:

http://www.eloxxpharma.com

Total Employee:

11+

Status:

Active

Contact:

+1-781-577-5300

Email Addresses:

[email protected]

Total Funding:

92.39 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Advisors List

martijn-kleijwegt_image

Martijn Kleijwegt Board of Director @ Eloxx
Board_member

silvia-noiman_image

Silvia Noiman Board Member @ Eloxx
Board_member

Current Employees Featured

not_available_image

Vijay Modur
Vijay Modur Head of Research and Development @ Eloxx
Head of Research and Development
2021-04-01

greg-williams_image

Greg Williams
Greg Williams Chief Operating Officer @ Eloxx
Chief Operating Officer

not_available_image

Ali Hariri
Ali Hariri Chief Medical Officer @ Eloxx
Chief Medical Officer
2021-09-01

gregory-weaver_image

Gregory Weaver
Gregory Weaver Chief Financial Officer @ Eloxx
Chief Financial Officer
2017-09-01

robert-e-ward_image

Robert E. Ward
Robert E. Ward Chairman and Chief Executive Officer @ Eloxx
Chairman and Chief Executive Officer
2017-12-01

silvia-noiman_image

Silvia Noiman
Silvia Noiman Founder @ Eloxx
Founder

Founder

silvia-noiman_image

Silvia Noiman

Stock Details

Company's stock symbol is NASDAQ:ELOX

Acquisitions List

Date	Company	Article	Price
2021-04-01	Zikani Therapeutics	Zikani Therapeutics acquired by Eloxx	N/A
2017-06-03	Sevion Therapeutics	Sevion Therapeutics acquired by Eloxx	N/A

Investors List

the-cystic-fibrosis-foundation_image

Key Employee Changes

Date	New article
2021-09-08	Eloxx Pharmaceuticals Appoints Chief Medical OfficerAli Hariri, M.D. to Lead Clinical Development Efforts for Company Pipeline
2021-04-01	Eloxx nabs early-stage biotech Zikani Therapeutics, replaces CEO, research lead

Official Site Inspections

http://www.eloxxpharma.com Semrush global rank: 9.48 M Semrush visits lastest month: 150

Host Informations
Whois Informations

Loading ...